| Authors: |
Hennequart M; The Francis Crick Institute, London, UK. marc.hennequart@unamur.be.; NARILIS Institute, UNamur, Namur, Belgium. marc.hennequart@unamur.be., Mervant L; The Francis Crick Institute, London, UK., Stockis J; University of Cambridge, CRUK Cambridge Institute, Cambridge, UK.; de Duve Institute, UCLouvain, Brussels, Belgium., Coomes J; The Francis Crick Institute, London, UK., Zarou MM; The Francis Crick Institute, London, UK., Gerard L; NARILIS Institute, UNamur, Namur, Belgium., Tevel V; NARILIS Institute, UNamur, Namur, Belgium., Migeot V; NARILIS Institute, UNamur, Namur, Belgium., Pilley SE; The Francis Crick Institute, London, UK.; Department of Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA., Lee Y; The Francis Crick Institute, London, UK., Driscoll PC; The Francis Crick Institute, London, UK., Legrave NM; The Francis Crick Institute, London, UK.; Luxembourg institute of Health, Luxembourg, Luxembourg., Labuschagne CF; Human Metabolomics, Faculty of Natural and Agricultural Sciences, North-West University Potchefstroom, Potchefstroom, South Africa., Zani F; The Francis Crick Institute, London, UK.; Department of Pharmacology and Therapeutics, McGill University, Montreal, Quebec, Canada., Uribe AH; School of Cancer Sciences, Wolfson Wohl Cancer Research Centre, University of Glasgow, Glasgow, UK., Ferreira RMM; The Francis Crick Institute, London, UK., Cheung EC; The Francis Crick Institute, London, UK., Malanchi I; The Francis Crick Institute, London, UK., MacRae JI; The Francis Crick Institute, London, UK., Maddocks ODK; School of Cancer Sciences, Wolfson Wohl Cancer Research Centre, University of Glasgow, Glasgow, UK., Halim TYF; University of Cambridge, CRUK Cambridge Institute, Cambridge, UK., Vousden KH; The Francis Crick Institute, London, UK. karen.vousden@crick.ac.uk. |
